R Alejandro Sica

10PUBLICATIONS
133CO-AUTHORS
Respiratory diseasesMolecular targetsGene and molecular therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jan 06, 2026
Financial Toxicity of Hematologic Malignancy Therapies, Including Cellular Therapy and Its Impact on Access to Care: Prospective Pilot Study.

Lemchukwu Amaeshi, Lauren Laufer, Kateryna Fedorov

|Jul 25, 2025
CNS Involvement by North American-Adult T-cell Leukemia/Lymphoma Is Associated With Discrete Dissemination Patterns and Molecular Profiles, Involving XPO1 E571 and KLF2/PI3KCD in Selected Cases.

Nishi Shah, Melissa Suchanek, Astha Thakkar

|Jun 21, 2023
A Metabolically Optimized, Noncytotoxic Low-Dose Weekly Decitabine/Venetoclax in MDS and AML.

David Levitz, Yogen Saunthararajah, Kateryna Fedorov

|Mar 01, 2023
Improved outcomes for relapsed/refractory Hodgkin lymphoma after autologous transplantation in the era of novel agents.

Michael A Spinner, R A Sica, John S Tamaresis

|Oct 18, 2022
Lenalidomide and Eltrombopag for Treatment of Low- or Intermediate-Risk Myelodysplastic Syndrome: Result of a Phase II Clinical Trial.

Jesus D Gonzalez-Lugo, Suman Kambhampati, Abdulraheem Yacoub

|Mar 09, 2022
Patients Recently Treated for B-lymphoid Malignancies Show Increased Risk of Severe COVID-19.

Samuel M Rubinstein, Divaya Bhutani, Ryan C Lynch

Pageof 2

Frequent Collaborators

5 joint publications

Kira Gritsman

4 joint publications

Mendel Goldfinger

4 joint publications

Aditi Shastri

4 joint publications

Nishi Shah